Biocompatible adhesives

• US 6,780,510 B2
• Filed: 10/22/2002
• Issued: 08/24/2004
• Est. Priority Date: 12/29/2000
• Status: Expired due to Term

• Current Assignee: St Jude Medical Incorporated (Abbott Laboratories)
• Original Assignee: St Jude Medical Incorporated (Abbott Laboratories)
• Inventors: Ogle, Matthew F., McConico, Andrea L.
• Primary Examiner(s): Buttner, David J.
• Assistant Examiner(s): KEEHAN, CHRISTOPHER M
• Application Number:
  US10/278,054
• Publication Number:
  US 20030094237A1
• Time in Patent Office: 672 Days
• Field of Search: 428/413, 428/414, 623/2.1, 524/9, 524/10, 524/14, 524/21
• US Class Current: 428/413
• CPC Class Codes: A61L 24/046 obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds A61L24/043 takes precedence
• CPC Class Codes: C08L 63/00 Compositions of epoxy resins; Compositions of derivatives of epoxy resins
• CPC Class Codes: C09J 163/00 Adhesives based on epoxy resins; Adhesives based on derivatives of epoxy resins
• CPC Class Codes: Y10T 428/31511 Of epoxy ether
• CPC Class Codes: Y10T 428/31515 As intermediate layer

Abstract

Novel adhesive compositions are described that include an epoxyamine and, preferably, a curing agent. The adhesive composition can be used in surgical settings such as implanting bioprostheses and/or in manufacturing of bioprostheses. Biocompatible substrates can be adhered together by an adhesive bond formed by curing of the epoxyamine adhesive composition.

Claims

1. A prosthesis comprising a first substrate, the first substrate associated with an adhesive composition, the adhesive composition comprising an epoxyamine, wherein the concentration of the epoxyamine in the adhesive composition is between about 25 percent by weight and about 90 percent by weight and said adhesive composition is biocompatible.

2. The prosthesis of claim 1 wherein the adhesive composition comprises triglycidylamine.

3. The prosthesis of claim 1 wherein the prosthesis comprises a second substrate, wherein the first substrate and the second substrate are adhered by an adhesive bond formed from the adhesive composition.

4. The prosthesis of claim 3 wherein the second substrate is selected from the group consisting of tissue and synthetic materials.

5. The prosthesis of claim 1 wherein the adhesive composition further comprises a curing agent.

6. The prosthesis of claim 1 wherein the first substrate is selected from the group consisting of tissue and synthetic materials.

7. The prosthesis of claim 1 wherein the prosthesis is selected from the group consisting of heart valve prostheses, annuloplasty rings, surgical patches and pacemakers.

9. The prosthesis of claim 1 wherein said adhesive comprises a curing agent.

10. The prosthesis of claim 9 wherein said curing agent comprises a functional group selected from the group consisting of sulfur-containing functional groups, nitrogen-containing functional groups and oxygen-containing functional groups.

11. The prosthesis of claim 9 wherein said curing agent comprises a functional group selected from the group consisting of a thiol, an alcohol and an amine.

12. The prosthesis of claim 1 wherein said adhesive composition further comprises a flexibilizer.

13. The prosthesis of claim 12 wherein said flexibilizer is selected from the group consisting of collagen, albumin, glycosaminoglycans and combinations thereof.

14. The prosthesis of claim 3 wherein said adhesive bond is formed after at least about one minute.

15. The prosthesis of claim 9 wherein said curing agent is present between about 1 percent by weight and about 20 percent by weight of the adhesive composition.

16. The prosthesis of claim 12 wherein said flexibilizer is present between about 1 percent by weight and about 40 percent by weight of the adhesive composition.

17. The prosthesis of claim 1 wherein said adhesive composition further comprises a biological response modifier.

18. The prosthesis of claim 17 wherein said biological response modifier comprises transforming growth factor-beta.

19. The prosthesis of claim 2 wherein said adhesive bond has bond strength of at least about 0.01 kg/mm².

8. A prosthesis comprising at least two substrates, wherein at least two of the substrates are adhered together by an adhesive bond, the adhesive bond formed when an epoxyamine adhesive between the substrates is cured and said adhesive is biocompatible.

20. The prosthesis of claim 8 wherein said adhesive further comprises transforming growth factor-beta.

21. A prosthesis comprising a first substrate, the first substrate associated with an adhesive composition, the adhesive composition comprising an epoxyamine and a transforming growth factor-beta.

22. The prosthesis of claim 21 wherein said adhesive is biocompatible.